Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Geographic Atrophy
Related studies linked through entity extraction aliases.
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Status
- RECRUITING
- Phase
- NA
Oral Postbiotics in Patients With Macular Atrophy
- Status
- UNKNOWN
- Phase
- NA
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE2
ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE1
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression
- Status
- RECRUITING
- Phase
- N/A
Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy
- Status
- COMPLETED
- Phase
- PHASE2
A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE1
A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE2
A Study of NGM621 in Participants With Geographic Atrophy
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)
- Status
- COMPLETED
- Phase
- PHASE3
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)
- Status
- WITHDRAWN
- Phase
- PHASE2
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE1
Study of NGM621 in Participants With Geographic Atrophy
- Status
- COMPLETED
- Phase
- PHASE1
A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
- Status
- TERMINATED
- Phase
- PHASE2
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
- Status
- TERMINATED
- Phase
- N/A